DR. CECILIA SCHMIDT-SAROSI M.D.
Prescription History 1205846607
Obstetrics & Gynecology - Reproductive Endocrinology in New York, NY

Active since August 08, 2006Opted out of Medicare · through Jan 11, 2028
51 E 67TH ST, NEW YORK, NY 10065(212) 535-5350 Get Directions

NPPES record last updated: March 7, 2023. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Mar 7, 2023, Nov 6, 2019 (2 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CECILIA SCHMIDT-SAROSI M.D., an active Reproductive Endocrinology specialist practicing in New York, NY. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 307 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 70 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

11
Medications
307
Total Claims
771
30-Day Fills
Estradiol
Most Prescribed · 70 claims
View details
11 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. CECILIA SCHMIDT-SAROSI M.D. in 2023, with prescription volumes, average cost per fill, and NY state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other NY PrescribersVs. NY Avg

About Estradiol: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 70 Medicare prescriptions for Estradiol, about 1.8 times the volume of the typical New York prescriber of this medication (39). Medicare paid an average of $183.46 per fill, versus $122.77 statewide.

How often this provider prescribes it

This provider
70
NY average
39.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$183.46
NY average
$122.77

Gross Part D cost per fill; not the patient's out-of-pocket price.

174.5
30-Day Fills
standardized to 30-day supplies
5,200
Days of Medication
total across all patients in 2023

About Premarin: This medication is a female hormone. Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.

In 2023, this provider wrote 48 Medicare prescriptions for Premarin, about 2.1 times the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $531.47 per fill, versus $407.34 statewide.

How often this provider prescribes it

This provider
48
NY average
23.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$531.47
NY average
$407.34

Gross Part D cost per fill; not the patient's out-of-pocket price.

116
30-Day Fills
standardized to 30-day supplies
3,480
Days of Medication
total across all patients in 2023

About Vagifem: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 34 Medicare prescriptions for Vagifem, about 2.3 times the volume of the typical New York prescriber of this medication (15). Medicare paid an average of $675.38 per fill, versus $369.01 statewide.

How often this provider prescribes it

This provider
34
NY average
15.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$675.38
NY average
$369.01

Gross Part D cost per fill; not the patient's out-of-pocket price.

89.2
30-Day Fills
standardized to 30-day supplies
2,667
Days of Medication
total across all patients in 2023

About Estradiol-Norethindrone Acetat: This medication contains 2 female hormones: an estrogen (such as conjugated estrogen, estradiol) and a progestin (such as medroxyprogesterone, norethindrone, norgestimate). Show more ▾

Some brands of this medication may contain progesterone instead of a progestin. Progesterone and progestin both act like the form of the natural hormone (progesterone) produced by your body. This medication is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. The progestin or progesterone in this medication helps to reduce the risk of cancer of the uterus which can be caused by using estrogen. Women who have had their uterus removed do not need the progestin or progesterone. They should not use this combination medication. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen/progestin treatment.

In 2023, this provider wrote 29 Medicare prescriptions for Estradiol-Norethindrone Acetat, about 1.9 times the volume of the typical New York prescriber of this medication (15). Medicare paid an average of $164.49 per fill, versus $107.48 statewide.

How often this provider prescribes it

This provider
29
NY average
15.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$164.49
NY average
$107.48

Gross Part D cost per fill; not the patient's out-of-pocket price.

65.4
30-Day Fills
standardized to 30-day supplies
1,944
Days of Medication
total across all patients in 2023

About Yuvafem: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 27 Medicare prescriptions for Yuvafem, about 1.3 times the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $333.70 per fill, versus $192.75 statewide.

How often this provider prescribes it

This provider
27
NY average
21.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$333.70
NY average
$192.75

Gross Part D cost per fill; not the patient's out-of-pocket price.

75.4
30-Day Fills
standardized to 30-day supplies
2,260
Days of Medication
total across all patients in 2023

About Prempro: This medication contains 2 female hormones: an estrogen (such as conjugated estrogen, estradiol) and a progestin (such as medroxyprogesterone, norethindrone, norgestimate). Show more ▾

Some brands of this medication may contain progesterone instead of a progestin. Progesterone and progestin both act like the form of the natural hormone (progesterone) produced by your body. This medication is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. The progestin or progesterone in this medication helps to reduce the risk of cancer of the uterus which can be caused by using estrogen. Women who have had their uterus removed do not need the progestin or progesterone. They should not use this combination medication. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen/progestin treatment.

In 2023, this provider wrote 24 Medicare prescriptions for Prempro, about 1.6 times the volume of the typical New York prescriber of this medication (15). Medicare paid an average of $529.69 per fill, versus $371.60 statewide.

How often this provider prescribes it

This provider
24
NY average
15.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$529.69
NY average
$371.60

Gross Part D cost per fill; not the patient's out-of-pocket price.

47.4
30-Day Fills
standardized to 30-day supplies
1,400
Days of Medication
total across all patients in 2023

About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2023, this provider wrote 23 Medicare prescriptions for Levothyroxine Sodium, about 18% of the volume of the typical New York prescriber of this medication (129). Medicare paid an average of $25.87 per fill, versus $18.60 statewide.

How often this provider prescribes it

This provider
23
NY average
129.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$25.87
NY average
$18.60

Gross Part D cost per fill; not the patient's out-of-pocket price.

69
30-Day Fills
standardized to 30-day supplies
2,070
Days of Medication
total across all patients in 2023

About Escitalopram Oxalate: Escitalopram is used to treat depression and anxiety. Show more ▾

It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

In 2023, this provider wrote 16 Medicare prescriptions for Escitalopram Oxalate, about a third of the volume of the typical New York prescriber of this medication (53). Medicare paid an average of $12.17 per fill, versus $13.47 statewide.

How often this provider prescribes it

This provider
16
NY average
53.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.17
NY average
$13.47

This provider's average cost per fill is below the NY average for this medication.

46
30-Day Fills
standardized to 30-day supplies
1,380
Days of Medication
total across all patients in 2023

About Estradiol (Twice Weekly): This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 13 Medicare prescriptions for Estradiol (Twice Weekly), about 65% of the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $67.52 per fill, versus $123.85 statewide.

How often this provider prescribes it

This provider
13
NY average
20.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$67.52
NY average
$123.85

This provider's average cost per fill is below the NY average for this medication.

22
30-Day Fills
standardized to 30-day supplies
660
Days of Medication
total across all patients in 2023

About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a water pill (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

In 2023, this provider wrote 12 Medicare prescriptions for Spironolactone, about a third of the volume of the typical New York prescriber of this medication (37). Medicare paid an average of $42.73 per fill, versus $12.16 statewide.

How often this provider prescribes it

This provider
12
NY average
37.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$42.73
NY average
$12.16

Gross Part D cost per fill; not the patient's out-of-pocket price.

36
30-Day Fills
standardized to 30-day supplies
1,080
Days of Medication
total across all patients in 2023

About Estrace: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 11 Medicare prescriptions for Estrace, about 69% of the volume of the typical New York prescriber of this medication (16). Medicare paid an average of $541.47 per fill, versus $267.48 statewide.

How often this provider prescribes it

This provider
11
NY average
16.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$541.47
NY average
$267.48

Gross Part D cost per fill; not the patient's out-of-pocket price.

30.5
30-Day Fills
standardized to 30-day supplies
914
Days of Medication
total across all patients in 2023
No medications match the current filters.
= the 5 medications this provider prescribes most. More than typical Typical Less than typical= prescription volume vs the average NY prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NY average cost per fill.

About this data. The prescription history for DR. CECILIA SCHMIDT-SAROSI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Reproductive Endocrinology prescribing approach at this New York, NY practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.